Federated Hermes, Inc. Eq Rx, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.66 - $2.31 $17,876 - $24,876	-10,769 Reduced 43.42%	14,034 $31,000
Q2 2023 Aug 14, 2023	BUY	$1.61 - $1.96 $26,566 - $32,341	16,501 Added 198.76%	24,803 $46,000
Q1 2023 May 08, 2023	SELL	$1.8 - $2.83 $3,004 - $4,723	-1,669 Reduced 16.74%	8,302 $16,000
Q4 2022 Feb 13, 2023	BUY	$2.05 - $5.5 $5,928 - $15,906	2,892 Added 40.85%	9,971 $24,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $6,654 - $42,403	7,079 New	7,079 $35,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.